1. Home
  2. ABVC vs MLCI Comparison

ABVC vs MLCI Comparison

Compare ABVC & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.49

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

MLCI

Mount Logan Capital Inc.

HOLD

Current Price

$3.80

Market Cap

31.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVC
MLCI
Founded
2015
N/A
Country
United States
United States
Employees
N/A
21
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
31.3M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
ABVC
MLCI
Price
$1.49
$3.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
115.9K
34.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
2.63%
EPS Growth
7.14
N/A
EPS
N/A
N/A
Revenue
$509,589.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$2.68
52 Week High
$4.02
$8.68

Technical Indicators

Market Signals
Indicator
ABVC
MLCI
Relative Strength Index (RSI) 64.59 66.57
Support Level $1.00 $3.31
Resistance Level $1.71 $4.80
Average True Range (ATR) 0.11 0.22
MACD 0.01 0.12
Stochastic Oscillator 76.87 96.52

Price Performance

Historical Comparison
ABVC
MLCI

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.

Share on Social Networks: